Insufficient scRNA-seq data for expression of PLSCR2 at single-cell level.
Insufficient scRNA-seq data for expression of PLSCR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 20.49 | 89 / 89 | 12% | 0.20 | 112 / 901 |
| pancreas | 99% | 18.93 | 326 / 328 | 3% | 0.05 | 6 / 178 |
| lung | 92% | 9.23 | 531 / 578 | 9% | 0.18 | 106 / 1155 |
| thymus | 99% | 15.47 | 648 / 653 | 0% | 0.00 | 2 / 605 |
| ovary | 75% | 4.23 | 135 / 180 | 20% | 0.30 | 86 / 430 |
| prostate | 92% | 8.66 | 226 / 245 | 2% | 0.03 | 10 / 502 |
| esophagus | 78% | 4.85 | 1131 / 1445 | 13% | 0.23 | 23 / 183 |
| stomach | 86% | 5.64 | 308 / 359 | 5% | 0.09 | 14 / 286 |
| spleen | 88% | 7.20 | 212 / 241 | 0% | 0 | 0 / 0 |
| breast | 78% | 7.25 | 360 / 459 | 6% | 0.11 | 70 / 1118 |
| intestine | 76% | 7.45 | 735 / 966 | 6% | 0.10 | 32 / 527 |
| bladder | 71% | 5.71 | 15 / 21 | 6% | 0.13 | 29 / 504 |
| uterus | 68% | 3.51 | 115 / 170 | 4% | 0.06 | 19 / 459 |
| liver | 68% | 3.45 | 154 / 226 | 2% | 0.03 | 8 / 406 |
| blood vessel | 70% | 3.64 | 929 / 1335 | 0% | 0 | 0 / 0 |
| skin | 66% | 3.50 | 1186 / 1809 | 0% | 0 | 0 / 472 |
| adipose | 65% | 3.55 | 781 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 58% | 6.17 | 541 / 929 | 0% | 0 | 0 / 0 |
| adrenal gland | 53% | 1.88 | 136 / 258 | 0% | 0 | 0 / 230 |
| heart | 47% | 1.89 | 405 / 861 | 0% | 0 | 0 / 0 |
| brain | 34% | 1.34 | 890 / 2642 | 0% | 0 | 0 / 705 |
| muscle | 23% | 0.86 | 188 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0017121 | Biological process | plasma membrane phospholipid scrambling |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0017128 | Molecular function | phospholipid scramblase activity |
| Gene name | PLSCR2 |
| Protein name | Phospholipid scramblase Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2) |
| Synonyms | |
| Description | FUNCTION: May mediate accelerated ATP-independent bidirectional transbilayer migration of phospholipids upon binding calcium ions that results in a loss of phospholipid asymmetry in the plasma membrane. May play a central role in the initiation of fibrin clot formation, in the activation of mast cells and in the recognition of apoptotic and injured cells by the reticuloendothelial system.; FUNCTION: Isoform 1 has no prospholipid scramblase activity, due to the lack of a N-terminal proline-rich domain. FUNCTION: May mediate accelerated ATP-independent bidirectional transbilayer migration of phospholipids upon binding calcium ions that results in a loss of phospholipid asymmetry in the plasma membrane. . FUNCTION: May mediate accelerated ATP-independent bidirectional transbilayer migration of phospholipids upon binding calcium ions that results in a loss of phospholipid asymmetry in the plasma membrane. . |
| Accessions | ENST00000696113.1 [Q9NRY7-1] ENST00000497985.5 [Q9NRY7-2] ENST00000336685.6 [Q9NRY7-1] C9J636 ENST00000696120.1 [Q9NRY7-1] ENST00000463633.5 F8WEZ1 ENST00000610787.5 [Q9NRY7-1] ENST00000696119.1 [Q9NRY7-2] Q9NRY7 ENST00000489015.1 ENST00000613069.4 [Q9NRY7-3] |